Clinical trial
ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era (ELEGANT): A Randomized Control Trial
NCT06968533 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era (ELEGANT): A Randomized Control Trial
- Lead sponsor
- National Defense Medical Center, Taiwan
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2024
- Completion date
- June 1, 2027
- Enrollment
- 13,350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
artificial intelligence, asymptomatic diseases, cost-benefit analysis, early diagnosis, heart failure, ventricular dysfunction, left